Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01827527 · ClinicalTrials.gov registry record
Magnetic Resonance & Optical Spectroscopy Validation
A clinical trial of Validation Studies and Magnetic Resonance Spectroscopy, sponsored by AdventHealth Translational Research Institute.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT01827527: Recruiting study of Validation Studies and Magnetic Resonance Spectroscopy, sponsored by AdventHealth Translational Research Institute.
NCT01827527 is a study of Validation Studies and Magnetic Resonance Spectroscopy that is actively recruiting participants, run by AdventHealth Translational Research Institute. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01827527, a study of Validation Studies and Magnetic Resonance Spectroscopy, is actively recruiting participants, sponsored by AdventHealth Translational Research Institute.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop and refine techniques for using magnetic resonance and optical spectroscopy to investigate how your body uses energy.
Primary Outcome
The PCr decay (rate of PCr breakdown during ischemia) will be used to measure the ATP turnover rates (ATPase). After the baseline is established, the volunteer will be asked to perform contractions of the quadriceps (by slight kicking) for up to 45 seconds. . After kicking is stopped, the volunteer will remain still for an additional 5 minutes in order to allow the PCr peak to return to baseline. The ATPase experiment will also be performed by acquiring 31P Spectra every 6 seconds.
Conditions Studied
Study Locations (1)
Florida
- Translational Research Institute for Metabolism and Diabetes - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2013-03 |
| Est. Completion | 2025-12 |
What NCT01827527 shows while recruiting
NCT01827527 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Validation Studies appearing as the primary indexed condition, and to 0 interventions.
NCT01827527 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT01827527 about?
NCT01827527 is a clinical study titled "Magnetic Resonance & Optical Spectroscopy Validation". The purpose of this study is to develop and refine techniques for using magnetic resonance and optical spectroscopy to investigate how your body uses energy.
What is the current status of trial NCT01827527?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2013-03. Estimated completion is 2025-12.
What conditions does trial NCT01827527 study?
This clinical trial studies the following conditions: Validation Studies, Magnetic Resonance Spectroscopy.
Who is sponsoring clinical trial NCT01827527?
This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01827527 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Validation Studies
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia